Enabling rapid exploration of the genetic landscape
Inscripta is a gene-editing technology company dedicated to creating the tools needed to revolutionize how we feed, fuel, and heal humanity. This includes developing a family of CRISPR enzymes (called MADzymes), bespoke nucleases for researchers and commercial partners, and a full suite of gene-editing tools (software, instruments, and reagents) that will significantly increase the speed and efficiency of precision gene-editing. Formerly known as Muse Biotechnology, Inscripta is headquartered in Boulder, Colorado, with offices in Pleasanton, California.
- Location: Boulder, CO
- Paladin Initial Investment Date: February 2017